Preventive
PrivateLast Round
Seed
Oct 30, 2025
Total Funding Raised
$30M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Preventive is a biotechnology company that develops prenatal gene-editing technologies intended for the prevention of severe genetic conditions before birth.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Preventive Comparables
Compare Preventive with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Origin Genomics | 90% | |
| Bootstrap Bio, Inc. | 78% | |
| Prime Medicine | 66% | |
Preventive Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 30, 2025 |
Preventive Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SciFounders | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 6, 2026
Grew 43% QoQ from 7 to 10 employees.
Preventive Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Preventive's valuation, stock price, and market status.